MedPage Today) — An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using continuous glucose monitoring (CGM), a randomized trial showed.
Over 13 weeks, drops in HbA1c averaged…
Type 2 Diabetes Patients Also Reap Benefits of Automated Insulin Delivery

Leave a Comment Leave a Comment
